Where does Profound Medical Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Profound Medical Inc. ranks #9,106 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Profound Medical Inc. hold?

Profound Medical Inc. holds 35 US utility patents granted between 2015 and 2025, spanning 9 technology areas.

What is Profound Medical Inc.'s Innovation Score?

Profound Medical Inc. has an Innovation Score of 43.2 out of 100 (top 29% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Profound Medical Inc. focus on?

Profound Medical Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 35 patents, ranking #112 of 1,943 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Profound Medical Inc.'s patent grant rate increasing or decreasing?

Profound Medical Inc.'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Profound Medical Inc.'s patents?

Profound Medical Inc.'s patents average 15.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Profound Medical Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Profound Medical Inc.

USPTO PatentsView assignee record - 35 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Profound ranks #9,106 of 49,997 tracked US assignees by granted-patent volume, with 35 patents across 9 technology areas.

#9,106
of 49,997 US assignees by volume: Top 29%
by Innovation Score (43.2/100): 15.7
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9106 · Foreign Corporation #9,106 · 35 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 35 grants
UPPER-Q #9,106/49,997
PHOTO-FINISH Pari Pharma
CPC-NARROW A61N · 9 areas
INNOV-PAR 43.2/100
CLAIMS-RICH 15.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Pari Pharma GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Profound’s 43.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.4 pts (29%) Velocity 10.8 pts (25%) Breadth 10.6 pts (25%) Claim depth 9.4 pts (22%)

Qualcomm Incorporated · highest

85
Facense · near

43
Inaeris · near

43
Industrial Scientific · near

43
Nidec Elesys · near

43
Profound Medical · this assignee

43
3D Lighting… · lowest

7

What this shows Profound's Innovation Score is 43.2/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Profound?

Each dot is one of Profound’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Profound’s own 15.7 claims/patent is at or below the 18.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Profound vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Profound's grants concentrate

Profound Medical Inc. is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2018 (8 grants) versus a trough of 2 in 2015. By volume, Profound sits between Pari Pharma GmbH and Raise Marketplace, LLC.

Profound's three-year grant acceleration

Profound Medical Inc. shows 13 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Pari Pharma

35
Pluto

35
Polymer Technolog…

35
Portland State Un…

35
Project Canary PBC

35
Psomagen

35
Rijksuniversiteit…

35
Raise Marketplace

35
Profound Medical ◀

35

What this shows Profound holds 35 patents at rank #9,105, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Profound

By rank, the assignees closest to #9,105 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Profound's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Profound, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Profound ranks #112 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (43 here).

Nidec Elesys Corporation 43 Inaeris Technologies, LLC 43 Industrial Scientific Corporation 43 Facense Ltd. 43

Profound's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 29% higher than 71% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Profound Medical Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	5.7%
2017	3	8.6%
2018	8	22.9%
2019	4	11.4%
2021	4	11.4%
2022	4	11.4%
2023	6	17.1%
2024	3	8.6%
2025partial year	1	2.9%

Which technologies does Profound Medical Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 35

A61B - DIAGNOSIS; SURGERY; Identification 33

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 7

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 3

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

A61G - Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices 2

B06B - Methods OR Apparatus FOR Generating OR Transmitting Mechanical Vibrations OF Infrasonic, Sonic, OR Ultrasonic Frequency, ; e.g.; FOR Performing Mechanical Work IN General 2

G06T - Image Data Processing OR Generation, IN General 1

G06F - Electric Digital Data Processing 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Profound Medical Inc.'s patent record in context - here's where to go next.

Profound Medical Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #9,106 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Profound Medical Inc. against Pari Pharma GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.